On January 3, 2018, Marrone Bio Innovations, Inc. announced that it has filed a preliminary proxy statement soliciting proxies and urged the shareholders to vote against a proposal from James McRitchie, asking the board of directors of the Company to amend its bylaws or other documents, as necessary, to provide proxy access with essential elements for substantial implementation at the Company’s annual general meeting of shareholders scheduled to be held on January 31, 2018.